Novo Integrated Sciences Stock Last Dividend Paid
NVOSDelisted Stock | USD 0.04 0.01 17.57% |
Novo Integrated Sciences fundamentals help investors to digest information that contributes to Novo Integrated's financial success or failures. It also enables traders to predict the movement of Novo OTC Stock. The fundamental analysis module provides a way to measure Novo Integrated's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Novo Integrated otc stock.
Novo |
Novo Integrated Sciences OTC Stock Last Dividend Paid Analysis
Novo Integrated's Last Dividend Paid refers to dividend per share(DPS) paid to the shareholder the last time dividends were issued by a company. In its conventional sense, dividends refer to the distribution of some of a company's net earnings or capital gains decided by the board of directors.
More About Last Dividend Paid | All Equity Analysis
Last Dividend | = | Last Profit Distribution AmountTotal Shares |
Many stable companies today pay out dividends to their shareholders in the form of the income distribution, but high-growth firms rarely offer dividends because all of their earnings are reinvested back to the business.
CompetitionBased on the recorded statements, Novo Integrated Sciences has a Last Dividend Paid of 0.0. This indicator is about the same for the Health Care Providers & Services average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Did you try this?
Run Money Managers Now
Money ManagersScreen money managers from public funds and ETFs managed around the world |
All Next | Launch Module |
Novo Fundamentals
Return On Equity | -1.35 | ||||
Return On Asset | -0.18 | ||||
Profit Margin | (1.80) % | ||||
Operating Margin | (0.80) % | ||||
Current Valuation | 5.8 M | ||||
Shares Outstanding | 19.05 M | ||||
Shares Owned By Insiders | 6.82 % | ||||
Shares Owned By Institutions | 5.77 % | ||||
Number Of Shares Shorted | 274.86 K | ||||
Price To Book | 0.29 X | ||||
Price To Sales | 0.21 X | ||||
Revenue | 12.57 M | ||||
Gross Profit | 3.82 M | ||||
EBITDA | (5.63 M) | ||||
Net Income | (13.27 M) | ||||
Cash And Equivalents | 12.68 M | ||||
Cash Per Share | 0.41 X | ||||
Total Debt | 4.47 M | ||||
Debt To Equity | 0.48 % | ||||
Current Ratio | 1.58 X | ||||
Book Value Per Share | 0.52 X | ||||
Cash Flow From Operations | (2.24 M) | ||||
Short Ratio | 1.13 X | ||||
Earnings Per Share | (0.41) X | ||||
Number Of Employees | 127 | ||||
Beta | -0.69 | ||||
Market Capitalization | 2.84 M | ||||
Total Asset | 35.56 M | ||||
Retained Earnings | (67.03 M) | ||||
Working Capital | (3.52 M) | ||||
Net Asset | 35.56 M |
About Novo Integrated Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Novo Integrated Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Novo Integrated using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Novo Integrated Sciences based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Consideration for investing in Novo OTC Stock
If you are still planning to invest in Novo Integrated Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Novo Integrated's history and understand the potential risks before investing.
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |